SynthesisFrontiers in oncology2026

Efficacy of first-line immune checkpoint inhibitors in advanced non-small-cell lung cancer with or without brain metastases: a systematic review and network meta-analysis.

Jie Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.